Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | E2F3 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | ASCC3 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | PHF5A | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | E2F5 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | PTBP1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | LRRC40 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
mRNA | HNRNPC | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
mRNA | NUS1 | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | TSPAN4 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | FTH1 | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |